290
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma

, , , , &
Pages 7-14 | Received 28 Aug 2019, Accepted 05 Feb 2020, Published online: 02 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianmin Xu, Yueping Yao, Binghua Xu, Yipeng Li & Zhijian Su. (2022) Unsupervised Learning of Cross-Modal Mappings in Multi-Omics data for Survival Stratification of Gastric Cancer. Future Oncology 18:2, pages 215-230.
Read now

Articles from other publishers (7)

Caitlin Sojka & Steven A. Sloan. (2024) Gliomas: a reflection of temporal gliogenic principles. Communications Biology 7:1.
Crossref
Zhe Zhang, Yusheng Chen, Yang Guo, Hanwei Shen, Jiangtao Wang & Hang Chen. (2023) RFX2 promotes tumor cell stemness through epigenetic regulation of PAF1 in spinal ependymoma. Journal of Neuro-Oncology 165:3, pages 487-497.
Crossref
Jian You, Bei Tao, Lilei Peng, Tangming Peng, Haiping He, Shan Zeng, Jizhong Han, Ligang Chen, Xiangguo Xia, Xiaobo Yang & Chuanhong Zhong. (2022) Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis. Cancer Gene Therapy 30:5, pages 683-693.
Crossref
Lairong Song, Xiaojie Li, Xiaoying Xu, Xulei Huo, Yi Zheng, Xiaomin Wang, Da Li, Junting Zhang, Ke Wang, Liang Wang & Zhen Wu. (2022) Comprehensive Analysis of the Prognostic Value and Molecular Function of CRNDE in Glioma at Bulk and Single-Cell Levels. Cells 11:22, pages 3669.
Crossref
Lili Guo & Dingsheng Liu. (2022) Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma. European Journal of Medical Research 27:1.
Crossref
Haojie Chen, Shiqi Tu, Chongze Yuan, Feng Tian, Yijing Zhang, Yihua Sun & Zhen Shao. (2022) HyperChIP: identification of hypervariable signals across ChIP-seq or ATAC-seq samples. Genome Biology 23:1.
Crossref
Joby Issac, Pooja S. Raveendran & Ani V. Das. (2021) RFX1: a promising therapeutic arsenal against cancer. Cancer Cell International 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.